Literature DB >> 23161203

Gamma-hydroxybutyrate (GHB) and topiramate--clinically relevant drug interaction suggested by a case of coma and increased plasma GHB concentration.

Tobias Weiss, Daniel Müller, Isabelle Marti, Caroline Happold, Stefan Russmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23161203     DOI： 10.1007/s00228-012-1450-z

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  4 in total

1.  Long-term efficacy of sodium oxybate in 4 patients with chronic cluster headache.

Authors:  R Khatami; S Tartarotti; M M Siccoli; C L Bassetti; P S Sándor
Journal:  Neurology       Date:  2011-05-25       Impact factor: 9.910

2.  gamma-Hydroxybutyrate conversion into GABA induces displacement of GABAB binding that is blocked by valproate and ethosuximide.

Authors:  V Hechler; C Ratomponirina; M Maitre
Journal:  J Pharmacol Exp Ther       Date:  1997-05       Impact factor: 4.030

3.  Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects.

Authors:  Rudolf Brenneisen; Mahmoud A Elsohly; Timothy P Murphy; Joseph Passarelli; Stefan Russmann; Salvatore J Salamone; David E Watson
Journal:  J Anal Toxicol       Date:  2004 Nov-Dec       Impact factor: 3.367

4.  [EEG changes during sedation with gamma-hydroxybutyric acid].

Authors:  E Entholzner; L Mielke; R Pichlmeier; F Weber; H Schneck
Journal:  Anaesthesist       Date:  1995-05       Impact factor: 1.041
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.